Impact of Dose and Titration Speed on the Tolerability of Xanomeline–Trospium in Schizophrenia
November 25, 2025
The latest news
Front of Mind News
Featured Post
Sustained Symptom Improvement Across Domains With Long-Term Xanomeline–Trospium Treatment
November 25, 2025
One year of xanomeline–trospium treatment sustained improvements across all schizophrenia symptom domains in EMERGENT-4. Patients switching from placebo caught up within just 4 weeks.
Read More
SUBSCRIBE TO OUR EMAIL
Get on the List
Other stories
